Cargando…

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with predominant myotonia and muscular dystrophy which is caused by CTG-repeat expansions in the DMPK gene. These repeat expansions are transcribed and the resulting mRNA accumulates RNA-binding proteins involved in splicing, resulting in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hintze, Stefan, Knaier, Lisa, Limmer, Sarah, Schoser, Benedikt, Meinke, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218431/
https://www.ncbi.nlm.nih.gov/pubmed/30425655
http://dx.doi.org/10.3389/fphys.2018.01532
_version_ 1783368449401028608
author Hintze, Stefan
Knaier, Lisa
Limmer, Sarah
Schoser, Benedikt
Meinke, Peter
author_facet Hintze, Stefan
Knaier, Lisa
Limmer, Sarah
Schoser, Benedikt
Meinke, Peter
author_sort Hintze, Stefan
collection PubMed
description Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with predominant myotonia and muscular dystrophy which is caused by CTG-repeat expansions in the DMPK gene. These repeat expansions are transcribed and the resulting mRNA accumulates RNA-binding proteins involved in splicing, resulting in a general splicing defect. We observed nuclear envelope (NE) alterations in DM1 primary myoblasts. These included invaginations of the NE as well as an altered composition of the nuclear lamina. Specifically, we investigated NE transmembrane proteins (NETs) in DM1 primary myoblasts, staining to determine if their distribution was altered compared to controls and if this could contribute to these structural defects. We also tested the expression of these NETs in muscle and how localization changes in the DM1 primary myoblasts undergoing differentiation in vitro to myotubes. We found no changes in the localization of the tested NETs, but most tended to exhibit reduced expression with increasing DMPK-repeat length. Nonetheless, the DM1 patient expression range was within the expression range of the controls. Additionally, we found a down-regulation of the possible nesprin 1 giant isoform in DM1 primary myoblasts which could contribute to the increased NE invaginations. Thus, nesprin 1 may be an interesting target for further investigation in DM1 disease pathology.
format Online
Article
Text
id pubmed-6218431
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62184312018-11-13 Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 Hintze, Stefan Knaier, Lisa Limmer, Sarah Schoser, Benedikt Meinke, Peter Front Physiol Physiology Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with predominant myotonia and muscular dystrophy which is caused by CTG-repeat expansions in the DMPK gene. These repeat expansions are transcribed and the resulting mRNA accumulates RNA-binding proteins involved in splicing, resulting in a general splicing defect. We observed nuclear envelope (NE) alterations in DM1 primary myoblasts. These included invaginations of the NE as well as an altered composition of the nuclear lamina. Specifically, we investigated NE transmembrane proteins (NETs) in DM1 primary myoblasts, staining to determine if their distribution was altered compared to controls and if this could contribute to these structural defects. We also tested the expression of these NETs in muscle and how localization changes in the DM1 primary myoblasts undergoing differentiation in vitro to myotubes. We found no changes in the localization of the tested NETs, but most tended to exhibit reduced expression with increasing DMPK-repeat length. Nonetheless, the DM1 patient expression range was within the expression range of the controls. Additionally, we found a down-regulation of the possible nesprin 1 giant isoform in DM1 primary myoblasts which could contribute to the increased NE invaginations. Thus, nesprin 1 may be an interesting target for further investigation in DM1 disease pathology. Frontiers Media S.A. 2018-10-30 /pmc/articles/PMC6218431/ /pubmed/30425655 http://dx.doi.org/10.3389/fphys.2018.01532 Text en Copyright © 2018 Hintze, Knaier, Limmer, Schoser and Meinke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Hintze, Stefan
Knaier, Lisa
Limmer, Sarah
Schoser, Benedikt
Meinke, Peter
Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
title Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
title_full Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
title_fullStr Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
title_full_unstemmed Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
title_short Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
title_sort nuclear envelope transmembrane proteins in myotonic dystrophy type 1
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218431/
https://www.ncbi.nlm.nih.gov/pubmed/30425655
http://dx.doi.org/10.3389/fphys.2018.01532
work_keys_str_mv AT hintzestefan nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1
AT knaierlisa nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1
AT limmersarah nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1
AT schoserbenedikt nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1
AT meinkepeter nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1